← Leaderboards
Eva-Maria Ratai
Tulane University Of Louisiana
$5,301,549
Attributed
$9,902,257
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,902,257 · 5
By mechanism
R01$9,363,599 · 3
R21$473,223 · 1
P51$65,435 · 1
Top collaborators
- Kejal Kantarci6 shared
- Marco Luciano Loggia6 shared
- Gulin Oz6 shared
Others in their field
Top investigators on “Magnetic Resonance Spectroscopy”
- Gregory S Boebinger · Florida State University$113,843,871
- Alex Lacerda · Florida State University$85,941,624
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$58,843,857
- John L Markley · University Of Wisconsin Madison$52,112,237
- Eric C Palm · Florida State University$31,951,397
- Stanley J Opella · Wistar Institute$30,798,621
Research focus
Magnetic Resonance SpectroscopyMagnetic Resonance ImagingNeurologicN-AcetylaspartateBrainBaseNeuroinflammationEnrollmentCohortImageImaging TechnologyAffectSiteNeuronsFundingInositolCholineGlutamatesInflammatorySymptomsBloodProspectivePathologyInfection
Grant awards (19)
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$620,430
R01 · FY2025 · NS
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$615,261
R01 · FY2024 · NS
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$638,887
R01 · FY2023 · NS
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$449,809
R01 · FY2023 · NS
Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV$1,186,451
R01 · FY2022 · DA
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$644,224
R01 · FY2022 · NS
Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV$627,474
R01 · FY2022 · DA
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy$721,322
R01 · FY2021 · NS
Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV$627,474
R01 · FY2021 · DA
Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV$627,474
R01 · FY2020 · DA
Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV$619,639
R01 · FY2019 · DA
Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV$592,994
R01 · FY2018 · DA
Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM$348,040
R01 · FY2018 · CA · contact PI
Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM$348,040
R01 · FY2017 · CA · contact PI
Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM$348,040
R01 · FY2016 · CA · contact PI
Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM$348,040
R01 · FY2015 · CA · contact PI
MRS OF NEUROPROTECTION IN AN SIV MODEL OF NEUROAIDS$215,310
R21 · FY2008 · NS · contact PI
MRS OF NEUROPROTECTION IN AN SIV MODEL OF NEUROAIDS$257,913
R21 · FY2007 · NS · contact PI
METABOLIC RESPONSES TO SIV INFECTION REVEALED BY IN VIVO ^1H MR SPECTROSCOPY$65,435
P51 · FY2006 · RR · contact PI